Loading...
XSHE
300246
Market cap272mUSD
May 30, Last price  
7.49CNY
1D
-1.19%
1Q
4.61%
Jan 2017
-66.31%
IPO
2.04%
Name

Guangdong Biolight Meditech Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
1.64
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.79%
Rev. gr., 5y
7.98%
Revenues
1.19b
+0.87%
86,314,031103,443,225143,634,086158,103,676182,285,238234,831,957288,993,464380,505,475594,314,416711,472,879813,385,394825,961,0941,396,013,5721,091,018,4341,183,699,6801,194,001,129
Net income
-65m
L
10,564,21920,405,07332,991,28933,775,32036,505,94028,923,72133,801,50223,918,99267,143,47457,547,28564,193,40164,712,757346,147,54863,792,59522,132,612-65,185,130
CFO
129m
-8.30%
12,675,16517,193,52540,087,80829,057,31240,515,47427,320,09742,310,64028,397,76050,805,21472,306,09181,207,34781,425,906455,780,88480,613,715140,721,997129,047,347
Dividend
May 25, 20230.3 CNY/sh

Profile

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG machines, fetal monitors, hemodialysis products, homecare medical products, medical pumps, veterinary monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America. Guangdong Biolight Meditech Co., Ltd. was founded in 1993 and is headquartered in Zhuhai, China.
URL
http://www.blt.com.cn
IPO date
Jul 19, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,194,001
0.87%
1,183,700
8.49%
Cost of revenue
1,008,266
1,109,860
Unusual Expense (Income)
NOPBT
185,736
73,840
NOPBT Margin
15.56%
6.24%
Operating Taxes
14,801
Tax Rate
7.97%
NOPAT
170,934
73,840
Net income
(65,185)
-394.52%
22,133
-65.31%
Dividends
(46,347)
(35,136)
Dividend yield
1.71%
1.25%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
270,773
153,141
Long-term debt
331,376
295,883
Deferred revenue
45,380
Other long-term liabilities
52,111
1
Net debt
103,432
(36,172)
Cash flow
Cash from operating activities
129,047
140,722
CAPEX
(220,335)
Cash from investing activities
(201,237)
Cash from financing activities
117,550
486,699
FCF
88,515
(389,964)
Balance
Cash
498,717
437,031
Long term investments
1
48,165
Excess cash
439,017
426,011
Stockholders' equity
849,341
1,005,355
Invested Capital
1,580,582
1,533,180
ROIC
10.98%
5.79%
ROCE
9.13%
3.74%
EV
Common stock shares outstanding
263,907
259,206
Price
10.30
-5.33%
10.88
-25.33%
Market cap
2,718,246
-3.61%
2,820,165
-11.67%
EV
2,899,729
2,870,155
EBITDA
243,858
125,080
EV/EBITDA
11.89
22.95
Interest
14,880
11,516
Interest/NOPBT
8.01%
15.60%